UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549

                               AMENDMENT NO. 1 TO

                                   FORM 10-QSB

              |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED September 30, 2003
                         Commission File Number 0-29057

      |_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

     For the transition period from __________________TO __________________

                          ALTRIMEGA HEALTH CORPORATION
               --------------------------------------------------
               (Exact name of registrant as specified in charter)

          NEVADA                                             87-0631750
-------------------------------                      --------------------------
(State or other jurisdiction of                      (I.R.S. Employer I.D. No.)

      4702 OLEANDER DRIVE, SUITE 200,
             MYRTLE BEACH, SC                                    29577
 ----------------------------------------                        -----
 (Address of principal executive offices)                        (Zip)

Issuer's telephone number, including area code      (843) 497-7028

          Securities registered pursuant to section 12 (b) of the Act:

     Title of each class           Name of each exchange on which registered
           NONE                                      NONE
           ----                                      ----

          Securities registered pursuant to section 12 (g) of the Act:

                    COMMON STOCK, PAR VALUE $0.001 PER SHARE
                    ----------------------------------------
                                (Title of Class)

               As of November 17, 2003, the Company had 49,139,950
                 shares of common stock issued and outstanding.

           Transitional Small Business Disclosure Format (check one).
                                     Yes |_| No |X|

<PAGE>

                                     PART I

                              FINANCIAL INFORMATION

INTRODUCTORY NOTE

      FORWARD-LOOKING STATEMENTS

      This Form 10-QSB contains "forward-looking statements" relating to
Altrimega Health Corporation ("Altrimega") which represent Altrimega's current
expectations or beliefs including, but not limited to, statements concerning
Altrimega's operations, performance, financial condition and growth. For this
purpose, any statements contained in this Form 10-QSB that are not statements of
historical fact are forward-looking statements. Without limiting the generality
of the foregoing, words such as "may", "anticipation", "intend", "could",
"estimate", or "continue" or the negative or other comparable terminology are
intended to identify forward-looking statements. These statements by their
nature involve substantial risks and uncertainties, such as losses, dependence
on management, variability of quarterly results, and the ability of Altrimega to
continue its growth strategy and competition, certain of which are beyond
Altrimega's control. Should one or more of these risks or uncertainties
materialize or should the underlying assumptions prove incorrect, actual
outcomes and results could differ materially from those indicated in the
forward-looking statements.

      Any forward-looking statement speaks only as of the date on which such
statement is made, and the Company undertakes no obligation to update any
forward-looking statement or statements to reflect events or circumstances after
the date on which such statement is made or to reflect the occurrence of
unanticipated events. New actors emerge from time to time and it is not possible
for management to predict all of such factors, nor can it assess the impact of
each such factor on the business or the extent to which any factor, or
combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements.


                                       2
<PAGE>

ITEM 1. FINANCIAL STATEMENTS

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEET
                         SEPTEMBER 30, 2003 (UNAUDITED)

<TABLE>
<CAPTION>
                             ASSETS                                                                 (RESTATED)
CURRENT ASSETS
<S>                                                                                               <C>
   Cash                                                                                           $     1,947
   Properties held for development or sale                                                            917,083
   Prepaid expenses                                                                                    10,841
                                                                                                  -----------
     Total Current Assets                                                                             929,871
                                                                                                  -----------
OTHER ASSETS
   Accounts receivable - related party                                                                 57,264
   Deposits                                                                                            35,000
                                                                                                  -----------
TOTAL ASSETS                                                                                      $ 1,022,135
                                                                                                  ===========

                         LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
   Notes payable                                                                                  $ 1,041,513
   Accounts payable - related parties                                                                 260,740
   Accounts payable                                                                                    45,507
                                                                                                  -----------
     Total Current Liabilities                                                                      1,347,760
                                                                                                  -----------
MINORITY INTEREST DEFICIENCY                                                                           (1,736)

STOCKHOLDERS'  DEFICIENCY
   Preferred stock
     10,000,000 shares authorized at $0.001 par value; 1,000,000 shares issued and outstanding          1,000
   Common stock
     50,000,000 shares authorized at $0.001 par value; 49,139,950 shares issued and outstanding        49,140
   Additional paid in capital                                                                         381,560
   Accumulated deficit                                                                               (755,589)
                                                                                                  -----------
       Total Stockholders' Deficit                                                                   (323,889)
                                                                                                  -----------
TOTAL LIABILITIES & STOCKHOLDERS DEFICIT                                                          $ 1,022,135
                                                                                                  ===========
</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       3
<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
        FOR THE NINE MONTHS AND THREE MONTHS ENDED SEPTEMBER 30, 2003 AND
              FOR THE PERIOD FROM JULY 3, 2002 (DATE OF INCEPTION)
                     THROUGH SEPTEMBER 30, 2002 (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                   Period from
                                                                                                   July 3, 2002
                                                              For the Three     For the Nine   (date of inception)
                                                              Months Ended      Months Ended         through
                                                              Sep 30, 2003      Sep 30, 2003      Sep 30, 2002
                                                                Restated          Restated         (Restated)
                                                              -------------     ------------   -------------------
<S>                                                             <C>              <C>                 <C>
SALES                                                           $ 271,679        $ 634,868           $     --

COST OF SALES                                                     260,775          583,023                 --
                                                                ---------        ---------           --------
Gross Profit                                                       10,904           51,845                 --
                                                                ---------        ---------           --------
EXPENSES
   Consultants                                                         --           69,500                 --
   Administrative                                                   9,820           38,954             41,086
                                                                ---------        ---------           --------
TOTAL EXPENSES                                                      9,820          108,454             41,086
                                                                ---------        ---------           --------
INCOME (LOSS) FROM OPERATIONS                                       1,084          (56,609)           (41,086)

OTHER EXPENSE
   Interest expense                                               (14,444)         (31,312)                --
                                                                ---------        ---------           --------
NET LOSS - before minority interest                               (13,360)         (87,921)           (41,086)

LESS MINORITY INTEREST                                              2,239           (1,405)                --
                                                                ---------        ---------           --------
NET LOSS                                                        $ (11,121)       $ (89,326)          $(41,086)
                                                                =========        =========           ========
NET LOSS PER COMMON SHARE
   Basic and diluted                                            $   (0.00)       $   (0.00)          $  (0.05)
                                                                =========        =========           ========
WEIGHTED AVERAGE OUTSTANDING SHARES - (stated in 1,000's)
   Basic and Diluted                                               49,140           49,052                816
                                                                =========        =========           ========
</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       4
<PAGE>

                        ALTRIMEGA HEALTH CORPORATION AND
                                   SUBSIDIARY
                CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS'
                                     DEFICIT

<TABLE>
<CAPTION>

                                  Preferred Stock               Common Stock          Additional                       Total
                               --------------------      --------------------------     Paid-In        Accumulated    Stockholders'
                                 Shares      Amount        Shares          Amount       Capital         Deficit        Deficit
                               ---------     ------      ----------       ---------   -----------    -------------   -------------
<S>                             <C>            <C>        <C>               <C>           <C>                 <C>            <C>
Balance at July 3, 2002
   (Inception)                         --     $   --              --      $     --      $      --      $      --      $      --

Issuance of common stock to
   founders for cash and
   founder services, $0.001            --         --      18,499,700        18,500        (15,300)            --          3,200

Issuance of common stock
   for acquisition of
   Altrimega Health
   Corporation, $0.001          1,000,000      1,000      22,020,000        22,020        (23,020)            --             --

Cancellation of shares                 --         --      (4,879,750)       (4,880)         4,880             --             --

Issuance of common stock
   for services, weighted
   average price of $0.03              --         --      10,500,000        10,500        338,500             --        349,000

Net loss                               --         --              --            --             --       (666,263)      (666,263)
                                ---------      -----      ----------        ------        -------       --------       --------

Balance at December 31,
   2002 (RESTATED)              1,000,000      1,000      46,139,950        46,140        305,060       (666,263)      (314,063)

Issuance of common stock in
   satisfaction of accounts
   and accrued interest,
   $0.03                               --         --       3,000,000         3,000         76,500             --         79,500

Net loss                               --         --              --            --             --        (89,326)       (89,326)
                                ---------      -----      ----------        ------        -------       --------       --------

Balance at September 30,
   2003 (RESTATED)
   (UNAUDITED)                  1,000,000     $1,000      49,139,950      $ 49,140      $ 381,560      $(755,589)     $(323,889)
                                =========     ======      ==========      ========      =========      =========      =========

</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       5
<PAGE>

                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
        FOR THE NINE MONTHS AND THREE MONTHS ENDED SEPTEMBER 30, 2003 AND
              FOR THE PERIOD FROM JULY 3, 2002 (DATE OF INCEPTION)
                     THROUGH SEPTEMBER 30,2002 (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                    Period from
                                                                                                    July 3, 2002
                                                                                                     (Date of
                                                                                                     Inception)
                                                                                                      Through
                                                                                        Sep 30,       Sep 30,
                                                                                         2003          2002
                                                                                       RESTATED      RESTATED
                                                                                      ---------      --------
CASH FLOWS FROM OPERATING ACTIVITIES
<S>                                                                                   <C>            <C>
   Net loss                                                                           $ (89,326)     $(60,866)

   Adjustments to reconcile net loss to net cash provided by operating activities

   Changes in
     Properties held for development or sale                                            439,135            --
     Accts receivable-related party                                                     (57,264)           --
     Prepaid commissions                                                                 (4,441)           --
     Accts payable-related                                                               10,740            --
     Accts payable                                                                       52,788        32,886
     Minority interest                                                                    1,405            --
                                                                                      ---------      --------
       Net Cash from Operations                                                         353,037            --

CASH FLOWS FROM FINANCING ACTIVITIES
       Common stock issued for cash                                                          --         3,200

CASH FLOWS FROM INVESTING ACTIVITIES                                                         --            --

   Payments on notes payable                                                           (398,134)           --
                                                                                      ---------      --------

   Net decrease in cash                                                                 (45,106)           --

   Cash at Beginning of Period                                                           47,053            --
                                                                                      ---------      --------

   Cash at End of Period                                                              $   1,947      $     --
                                                                                      =========      ========
</TABLE>

   The accompanying notes are an integral part of these financial statements.


                                       6
<PAGE>

                   ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2003
                                   (UNAUDITED)

1.    BASIS OF PRESENTATION

The accompanying unaudited condensed financial statements have been prepared in
accordance with Securities and Exchange Commission requirements for interim
financial statements. Therefore, they do not include all of the information and
footnotes required by accounting principles generally accepted in the United
States for complete financial statements. The financial statements should be
read in conjunction with the Form 10-KSB for the year ended December 31, 2002 of
Altrimega Health Corporation and Subsidiary (the "Company").

The interim financial statements present the condensed balance sheet, statements
of operations, stockholders' deficit and cash flows of Altrimega Health
Corporation and Subsidiary. The financial statements have been prepared in
accordance with accounting principles generally accepted in the United States.

The interim financial information is unaudited. In the opinion of management,
all adjustments necessary to present fairly the financial position of the
Company as of September 30, 2003 and the results of operations and cash flows
presented herein have been included in the financial statements. Interim results
are not necessarily indicative of results of operations for the full year.

The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

Going concern - The accompanying financial statements have been prepared on a
going concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. The Company
incurred a net loss of approximately $666,000 for the year ended December 31,
2002, with an accumulated loss from inception of approximately $666,000. The
Company's current liabilities exceed its current assets by approximately
$352,000 as of December 31, 2002. The Company had a net loss of $89,326 for the
nine months ended September 30, 2003 and an accumulated deficit of $755,589 at
September 30, 2003. The Company's current liabilities exceeded its current
assets by $417,889 at September 30, 2003.

These conditions give rise to substantial doubt about the Company's ability to
continue as a going concern. These financial statements do not include
adjustments relating to the recoverability and classification of reported asset
amounts or the amount and classification of liabilities that might be necessary
should the Company be unable to continue as a going concern. The Company's
continuation as a going concern is dependent upon its ability to obtain
additional financing or sale of its common stock as may be required and
ultimately to attain profitability.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Employee stock based compensation - The Company applies Accounting Principles
Board ("APB") Opinion No. 25, Accounting for Stock Issued to Employees, and
Related Interpretations, in accounting for stock options issued to employees.
Under APB No. 25, employee compensation cost is recognized when estimated fair
value of the underlying stock on date of the grant exceeds exercise price of the
stock option. For stock options and warrants issued to non-employees, the
Company applies Statement of Financial Accounting Standards ("SFAS") No. 123,
Accounting for Stock-Based Compensation, which requires the recognition of
compensation cost based upon the fair value of stock options at the grant date
using the Black-Scholes option pricing model.


                                       7
<PAGE>

                   ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARY
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2003
                                   (UNAUDITED)

The Company issued no stock and granted no warrants or options to employees for
compensation for the nine months ended September 30, 2003.

In December 2002, the Financial Accounting Standards Board issued SFAS No. 148,
"Accounting for Stock-Based Compensation-Transition and Disclosure". SFAS No.
148 amends the transition and disclosure provisions of SFAS No. 123. The Company
is currently evaluating SFAS No. 148 to determine if it will adopt SFAS No. 123
to account for employee stock options using the fair value method and, if so,
when to begin transition to that method.

3.    NOTES PAYABLE

As of September 30, 2003, the Company has four notes payable totaling $127,152,
$66,768, $445,000 and $402,593. The outstanding balances are secured by real
estate, payable in quarterly installments of interest only at the prime lending
rate plus 0.5% (4.5% as of December 31, 2002), which mature at various dates
between November 2003 and February 2004.

4.    RELATED PARTY TRANSACTIONS

Accounts payable - related parties - As of December 31, 2003,
officers-directors, and their controlled entities, have acquired 36% of the
outstanding stock of the Company, after the conversion of the preferred shares
to common shares, and have made non-interest bearing, due on demand loans to the
Company totaling $260,740.

Executive employment agreement - During 2003 the Company entered into an
employment agreement with an officer, which provides for an annual salary of
$100,000 with a 5% increase each year to a maximum of $125,000, provided the
Company has a profit in the previous year.

5.    STOCKHOLDERS' DEFICIT

During the first quarter of 2003, the Company issued 3,000,000 shares of common
stock in satisfaction of accounts payable of $79,500 (including accrued interest
of $39,500).

6.    RESTATED FINANCIAL STATEMENTS

Subsequent to the issuance of the Company's financial statements, management
became aware that those financial statements did not reflect account balances
properly for the period from July 3, 2002 (date of inception) through December
31, 2002. The change in the statement of operations primarily related to the
accounting of stock based compensation and the AHC Transaction, which was not
properly reported as a transaction identical to that resulting from a reverse
acquisition, except goodwill or other intangible assets are not recorded. The
net change of $171,756 increased the net loss from $494,507 ($0.01 per weighted
average common share outstanding) to $666,263 ($0.06 per weighted average common
share outstanding) for the period from July 3, 2002 (date of inception) through
December 31, 2002.

Additionally, the issuance of the financial statements as of and for the period
ended September 30, 2003 as reported did not properly reflect certain historical
balances. Therefore, the financial statement presentation has been restated to
conform to the proper reporting of these transactions.


                                       8
<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

      PLAN OF OPERATION

            GENERAL

      The following discussion and analysis should be read in conjunction with
the Consolidated Financial Statements, and the Notes thereto included herein.
The information contained below includes statements of Altrimega's or
management's beliefs, expectations, hopes, goals and plans that, if not
historical, are forward-looking statements subject to certain risks and
uncertainties that could cause actual results to differ materially from those
anticipated in the forward-looking statements. For a discussion on
forward-looking statements, see the information set forth in the Introductory
Note to this Annual Report under the caption "Forward Looking Statements", which
information is incorporated herein by reference.

      GOING CONCERN

      As reflected in Altrimega's financial statements for the six months ended
September 30, 2003, Altrimega's accumulated deficit of $755,589 and its working
capital deficiency of $417,889 raise substantial doubt about its ability to
continue as a going concern. The ability of Altrimega to continue as a going
concern is dependent on Altrimega's ability to raise additional debt or capital.
The financial statements for September 30, 2003 do not include any adjustments
that might be necessary if Altrimega is unable to continue as a going concern.

      CRITICAL ACCOUNTING POLICIES AND ESTIMATES

      Management's discussion and analysis of our financial condition and
results of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America. The preparation of these financial
statements requires that we make estimates and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses. At each balance
sheet date, management evaluates its estimates. We base our estimates
unhistorical experience and on various other assumptions that are believed to be
reasonable under the circumstances. Actual results may differ from these
estimates under different assumptions or conditions. The estimates and critical
accounting policies that are most important in fully understanding and
evaluating our financial condition and results of operations include those
listed below.

      REVENUE RECOGNITION

      Gains from sales of operating properties and revenues from land sales are
recognized using the full accrual method provided that various criteria relating
to the terms of the transactions and any subsequent involvement by the Company
with the properties sold are met. Gains or revenues relating to transactions
which do not meet the established criteria are deferred and recognized when the
criteria are met or using the installment or cost recovery methods, as
appropriate in the circumstances. For land sale transactions under terms in
which the Company is required to perform additional services and incur
significant costs after title has passed, revenues and costs of sales are
recognized proportionately on a percentage of completion basis. Deposits
received prior to closing are recorded as a liability until the consummation of
the sale at which time such amounts are generally applied toward the purchase
price.

      Cost of land sales is generally determined as a specific percentage of
land sales revenues recognized for each land development project. The cost
percentages used are based on estimates of development costs and sales revenues
to completion of each project and are revised periodically for changes in
estimates or development plans. The specific identification method is used to
determine cost of sales of certain parcels of land.

      PROPERTIES

      Properties under development are carried at cost reduced for impairment
losses, where appropriate. Properties held for sale are carried at cost reduced
for valuation allowances, where appropriate. Acquisition, development and
construction costs of properties in development and land development projects
are capitalized including, where applicable, salaries and related costs, real
estate taxes, interest and preconstruction costs. The pre-construction
development (or an expansion of an existing property) includes efforts and
related costs to secure land control and zoning, evaluate feasibility, and
complete other initial tasks, which are essential to development. Provisions
are made for potentially unsuccessful preconstruction efforts by charges to
operations.


                                       9
<PAGE>

      Properties held for sale are carried at the lower of their carrying values
(i.e., cost less accumulated depreciation and any impairment loss recognized,
where applicable) or estimated fair values less costs to sell. Generally,
revenues and expenses related to property interests acquired with the intention
to resell are not recognized.

      STOCK-BASED COMPENSATION - The Company applies Accounting Principles Board
("APB") Opinion No. 25, Accounting for Stock Issued to Employees, and Related
Interpretations, in accounting for stock options issued to employees. Under APB
No. 25, employee compensation cost is recognized when estimated fair value of
the underlying stock on date of the grant exceeds exercise price of the stock
option. For stock options and warrants issued to non-employees, the Company
applies SFAS No. 123, Accounting for Stock-Based Compensation, which requires
the recognition of compensation cost based upon the fair value of stock options
at the grant date using the Black-Scholes option pricing model.

      In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based
Compensation-Transition and Disclosure. SFAS No. 148 amends the transition and
disclosure provisions of SFAS No. 123. The Company is currently evaluating SFAS
No. 148 to determine if it will adopt SFAS No. 123 to account for employee stock
options using the fair value method and, if so, when to begin transition to that
method.

      PRINCIPLES OF CONSOLIDATION

      The consolidated financial statements shown in this report excludes the
historical operating information of the parent before September 30, 2002, and
includes the operating information of the subsidiary, Creative Holdings, Inc.,
from July 3, 2002 (date of inception of the subsidiary), and the operating
information of Sea Garden Funding, LLC from November 2002 (the date of the
purchase of 80% of the LLC) to September 30, 2003.

      All intercompany transactions have been eliminated.

      RESTATEMENT OF FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31,
      2002

      Subsequent to the issuance of the Company's financial statements,
management became aware that those financial statements did not reflect account
balances properly for the period from July 3, 2002 (date of inception) through
December 31, 2002. Properly accounting of these items in the revised financial
statements has the following effect:

      For the period from July 3, 2002 (date of inception) through December 31,
2002, the change in the statement of operations primarily related to the
accounting for the share exchange agreement between Altrimega and Creative
Holdings, which was not properly reported as a transaction identical to that
resulting from a reverse acquisition, except goodwill or other intangible assets
are not recorded. The net change of $171,756 increased the net loss from
$494,507 ($0.01 per weighted average common share outstanding) to $666,263($0.06
per weighted average common share outstanding) for the period from July 3, 2002
(date of inception) through December 31, 2002. The Company has filed an
amendment to its Form 10-KSB for fiscal year ended December 31, 2002.

      Additionally, the issuance of the financial statements as of and for the
period ended September 30, 2003 as reported did not properly reflect certain
historical balances. Therefore, the financial statement presentation has been
restated to conform to the proper reporting of these transactions.

      RESULTS OF OPERATIONS FOR THE THREE MONTH PERIOD ENDED SEPTEMBER 30, 2003,
      COMPARED TO THE PERIOD FROM JULY 3, 2002 (DATE OF INCEPTION) THROUGH
      SEPTEMBER 30, 2002

            REVENUES

      Revenue for the three month period ended September 30, 2003, was $271,679,
an increase of $271,679, as compared to $-0- in revenues for the period from
July 3, 2002 (date of inception) through September 30, 2002. The increase in
revenues in 2003 was attributable to sales of units at the Sea Garden project
during 2003. The Company had no operations and no revenues in the period ended
September 30, 2002.


                                       10
<PAGE>

      COST OF REVENUE. There was $260,775 cost of revenues for the three month
period ended September 30, 2003, as opposed to no cost of revenues in the period
from July 3, 2002 (date of inception) through September 30, 2002. The cost of
revenue relates to construction and other costs of units at the Sea Garden
project.

      GROSS PROFIT. There was $10,904 in gross profit for the three month period
ended September 30, 2003. There was no gross profit for the period from July 3,
2002 (date of inception) through September 30, 2002 as there were no operations.
The gross profit relates to the sale of units at the Sea Garden project.

      OPERATING EXPENSES. Operating expenses for the three month period ended
September 30, 2003, were $9,820, as compared to $41,806, for the period from
July 3, 2002 (date of inception) through September 30, 2002. Operating expenses
in 2003 consisted of $-0- in consulting fees and $9,820 in general and
administrative expenses. The decrease of $31,266 from 2002 to 2003 was
attributable to lower administrative expenses.

      NET PROFIT (LOSS). Altrimega realized a net loss of $11,121 for the three
month period ended September 30, 2003, as compared to a net loss of $41,086 for
the period from July 3, 2002 (date of inception) through September 30, 2002. The
Company's net loss for the nine months ended September 30, 2003 was $89,326. The
difference was attributable to the Company's real estate operations in 2003.

      LIQUIDITY AND CAPITAL RESOURCES

      Altrimega's financial statements have been prepared on a going concern
basis that contemplates the realization of assets and the settlement of
liabilities and commitments in the normal course of business. Altrimega realized
a net loss of $89,326 for the nine month period ended September 30, 2003, and
has an accumulated deficit of $755,589 at September 30, 2003. As of September
30, 2003, we had assets of $1,022,135 and liabilities of $1,347,760, a
difference of $325,625. Additionally, our current assets were $929,871 and our
current liabilities were $1,347,760, creating a working capital deficit of
$417,889. The majority of the assets, $917,083 consist of building sites
contained within the Sea Garden town home community. Consequently, the majority
of our liabilities, $1,041,513, are mortgage loans on the Sea Garden assets.
Accounts payable to related parties equal to $260,740 are also included in our
liabilities. Management recognizes that Altrimega must generate or obtain
additional capital to enable it to continue operations. Management is planning
to obtain additional capital principally through the sale of equity securities.
The realization of assets and satisfaction of liabilities in the normal course
of business is dependent upon Altrimega obtaining additional equity capital and
ultimately obtaining profitable operations. However, no assurances can be given
that Altrimega will be successful in these activities. Should any of these
events not occur, the accompanying consolidated financial statements will be
materially affected.

      We had limited operations and revenues during the period ended September
30, 2003. Our shortfall in working capital has been met through advances from
our president, John Gandy, and other shareholders who have advanced funds to pay
expenses incurred by the Company from time to time. At no time during the period
did these short term loans exceed $50,000.

      We anticipate that we will require significant capital to maintain our
corporate viability and execute our plan to develop real estate projects. We
anticipate necessary funds will most likely be provided by our existing
shareholders, our officers and directors, and outside investors. We will require
significant loan guarantees to acquire properties for development and to
complete construction on any additional construction projects. We may be
required to pledge equity in the Company to induce individuals, officers or
directors or other shareholders to guarantee our loans when necessary.

      Altrimega is at present meeting its current obligations from its monthly
cash flows, which during 2002, and to date in 2003 has included cash from
operations, investor capital, and loans from related parties. However, due to
insufficient cash generated from operations, Altrimega currently does not have
internally generated cash sufficient to pay all of its incurred expenses and
other liabilities. As a result, Altrimega is dependent on investor capital and
loans to meet its expenses and obligations. Although related party loans have
allowed Altrimega to meet its obligations in the recent past, there can be no
assurances that Altrimega's present methods of generating cash flow will be
sufficient to meet future obligations. There can be no assurances that Altrimega
will be able to raise sufficient additional capital in the future.

      We have incurred losses since inception. Management believes that it will
require approximately $150,000 in additional capital to fund overall Company
operations for the next twelve months. This amount does not include monies
necessary to construct new townhouse units at Sea Garden. Altrimega had
approximately $1,947 in cash and cash equivalents as of September 30, 2003.


                                       11
<PAGE>

      PLAN OF OPERATION

      The Company derives it revenue from the sale of developed or undeveloped
real estate parcels. At present, the Company has one project generating
revenues, Sea Garden Town Homes, located in North Myrtle Beach, South Carolina
These Town Homes sell in the $95,000 to $105,000 range per Town Home unit. The
Company owns the building sites for an additional 49 units and is under
construction on 15 units. It is important for the Company to raise capital funds
through the sell of its common stock in order to provide funding for additional
projects. The projected revenues and subsequent net earnings from the Sea Garden
project are not adequate to cover the Company's annual operating costs on an
ongoing basis.

      Altrimega intends to strive to locate, evaluate and proceed to finance and
develop multiple projects located primarily in the Myrtle Beach, South Carolina
area and the Carolinas area of the United States. Management believes that these
areas provide the population growth necessary to achieve profits from new
construction projects. For the last three years, Horry County, South Carolina
has been one of the top three fastest growing counties in the United States. In
1997, Horry County showed a population of only 180,000. Based on current
projections and the 2000 census data, the county will have a permanent
population of 500,000. The principal industries of the area are tourism related.
Myrtle Beach is considered a drive-in market, where tourists will drive their
cars rather than fly to the destination. The tourism industry in Myrtle Beach
has developed three seasons, spring golf, summer beach vacations and fall golf.
The spring and fall golf seasons bring approximately 150,000 visitors per week
to play on the areas over 100 golf courses. The summer vacation season brings in
approximately 400,000 per week. The average tourist stay is one week.

      Altrimega's business strategy includes a focus on interval ownership
properties, also known as time-share properties, that cater to this major
tourism industry. As well, we intend to develop projects in the medium price
ranges for the areas permanent service industry population.

      Management intends to attempt to seek out low-risk projects that do not
require large financing commitments. In addition, we will continue to evaluate
projects throughout the Carolinas in high growth areas.

      Our continuation as a going concern is dependent on our ability to meet
our obligations and obtain additional debt or equity financing required until
our current and proposed real estate projects are under way and generating
earnings. Until such time as these projects are generating earnings, we have
taken the following steps to revise our operating and financial requirements in
an effort to enable us to continue in existence:

      o     We have reduced administrative expenses to a minimum by
            consolidating management responsibilities to our president and chief
            executive officer.

      o     We intend to seek either equity or further debt funding.

      o     We intend to attempt to obtain the professional services of
            third-parties through favorable financing arrangements or payment by
            the issuance of our common stock.

      We believe that the foregoing plan should enable us to generate sufficient
funds to continue its operations for the next twelve months.

      Management has implemented this plan to overcome the Company's serious
going concern conditions. The first step is to reduce operating costs. To this
end the Company's President and Chief Executive Officer, John Gandy, has assumed
almost all of the Company's functions from sales and marketing, locating and
evaluating new real estate projects, most accounting functions, shareholder
relations and general administrative functions. The Company's Chief Financial
Officer is receiving no compensation. The Company anticipates reduced consulting
expense in the next fiscal year. Only one consultant is on hand for additional
help in evaluating projects and working with the accounting and reporting
functions of the Company. Administrative expenses, including mostly legal and
accounting charges, will constitute the largest expense items for the year. The
Company has made arrangements with these outside professionals to work more
efficiently with them to help reduce the overall costs associated with these
services.

      In addition, the Company has located some potential sources of equity
financing that could contribute to the Company's financial requirements in the
upcoming fiscal year. This element is especially critical to the Company's going
concern situation. Before these sources can be fully explored, the Company must
correct some of its prior filings with the Securities and Exchange Commission.
Management is in the process of correcting its prior 1934 Securities Act
filings, including its annual report of for 10-KSB for the fiscal year ended
December 31, 2002, and its quarterly reports on Forms 10-QSB for the quarters
ended March 31, 2003, June 30, 2003 and September 30, 2003, including this
amended report for the September 30, 2003 period.

                                       12
<PAGE>

      For the next 12 months we anticipate that we will need $150,000 to
continue to fund basic operations, in addition to funding necessary to acquire
and develop real estate projects. The Company anticipates approximately $50,000
in consulting fees in the next fiscal year and only minor operating expenses.
Any new real estate projects will require debt financing. In summary, we expect
expenses to decline in the coming fiscal year due to a decrease in consulting
fees and no other increases in operating expenses.

      The Company plans to continue operating with small administrative and
consulting fees in the next fiscal year in order to continue operations.
Continuing to work with its accounting and legal professionals more efficiently,
the Company plans to reduce its fees for such services. In addition, the Company
plans to utilize only one consultant for accounting services.

      From time to time, Altrimega may evaluate potential acquisitions involving
complementary businesses, content, products or technologies. Altrimega has no
present agreements or understanding with respect to any such acquisition.
Altrimega's future capital requirements will depend on many factors, including
an increase in Altrimega's real estate projects, and other factors including the
results of future operations.

ITEM  3. CONTROLS AND PROCEDURES

      (A)   EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

      As of the end of the period covered by this report, the Company carried
out an evaluation, under the supervision and with the participation of the
Company's Principal Executive Officer and Principal Financial Officer of the
effectiveness of the design and operation of the Company's disclosure controls
and procedures. The Company's disclosure controls and procedures are designed to
provide a reasonable level of assurance of achieving the Company's disclosure
control objectives. The Company's Principal Executive Officer and Principal
Accounting Officer have concluded that the Company's disclosure controls and
procedures are, in fact, effective at this reasonable assurance level as of the
period covered.

      (B)   CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

      In connection with the evaluation of the Company's internal controls
during the Company's quarter ended September 30, 2003, the Company's Principal
Executive Officer and Principal Financial Officer have determined that there are
no changes to the Company's internal controls over financial reporting that has
materially affected, or is reasonably likely to materially effect, the Company's
internal controls over financial reporting.


                                       13
<PAGE>

                                     PART II

                                OTHER INFORMATION

ITEM 1. LEGAL PROCEDURES

      None.

ITEM 2. CHANGES IN SECURITIES

      (a) Effective September 30, 2002, Altrimega issued Series A Preferred
Stock. The rights of holders of Series A Preferred Stock are set forth in the
Certificate of Designation filed as an Exhibit 4.01 to Altrimega's Form 10-KSB,
filed on May 20, 2003. Each share of the series is convertible, at the option of
the holder, into three hundred shares of common stock.

      (b) None.

      (c) None.

      (d) None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

      None.

ITEM 4. SUBMISSION OF MATTERS TO BE A VOTE OF SECURITY HOLDERS

      None.

ITEM 5. OTHER INFORMATION

      None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

      (a)(1) EXHIBITS. The following exhibits are included as part of this
report:

<TABLE>
<CAPTION>
SEC
EXHIBIT     REFERENCE
NUMBER      NUMBER       TITLE OF DOCUMENT                                   LOCATION
<S>         <C>          <C>                                                 <C>
2.01        2            SHARE EXCHANGE AGREEMENT among Altrimega            Incorporated by reference to the Company's
                         Health Corporation, Creative                        report on Form 8-K
                         Holdings, Inc. and the                              dated October 2, 2002
                         Shareholders of Creative
                         Holdings, Inc., dated as
                         of September 2, 2002

4.01        4
                         CERTIFICATE OF DESIGNATION AS OF SEPTEMBER 30,      Incorporated by reference   to Exhibit 4.01
                         2002                                                to the Company's Form 10-KSB
                                                                             filed on May 20, 2003
</TABLE>


                                       14
<PAGE>

      (b) REPORTS ON FORM 8-K. During the quarter ended September 30, 2003 we
filed current reports on Form 8-K with the Commission reporting that:

May 20, 2003      Altrimega filed Amendment No. 2 to Form 8-K/A, filing the
                  financial statements required under reporting that under Item
                  7, as a result of the Share Exchange Agreement with Creative
                  Holdings, Inc.


                                       15
<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

AUGUST 6, 2004                         ALTRIMEGA HEALTH CORPORATION

                                       By:  /s/ John Gandy
                                            ----------------------
                                            John Gandy,
                                            Chief Executive Officer and
                                            Director

AUGUST 6, 2004                         By:  /s/ Ron Hendrix
                                            ----------------------
                                            Ron Hendrix,
                                            Chief Financial Officer and
                                            Secretary


                                       16